Last checked at 25 Aug 2016 07:00
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Notice of Results
The neuroscience company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG), which develops and markets near patient technologies for the assessment of brain health to improve the drug development process, will be reporting its interim results for the six months ended 30 June 2016 on Thursday 22 September 2016.
Enquiries:
Cambridge Cognition Holdings plc | www.cambridgecognition.com | |
Steven Powell, Chief Executive Officer | Tel: 01223 810 700 | |
Nick Walters, Chief Financial Officer | ||
finnCap Ltd (Nomad and Joint Broker) | Tel: 020 7220 0500 | |
Geoff Nash/Simon Hicks | (Corporate Finance) | |
Alice Lane | (Corporate Broking) | |
Hybridan LLP (Joint Broker) | Tel: 020 3764 2341 | |
Claire Noyce | (Corporate Broking) | |
About Cambridge Cognition
Cambridge Cognition is an international neuroscience company which develops and markets near patient cognitive assessment products to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders.
For over 30 years the company's patented technology has advanced the assessment of cognition to accelerate the development of safe and effective treatments, improve patient outcomes and monitor and manage cognitive health throughout life.
Partners include the world's leading biotechnology and pharmaceutical companies; leading academic institutions; and public-private healthcare providers.
www.cambridgecognition.com